Broad-spectrum antibiotic their greater potential to disrupt a larger variety of normal human flora. After continued exposure to an antibiotic, bacteria may develop changes in their structure or function that make them resistant to the antibiotic. These resistant organisms will live, while the susceptible organisms will die, leaving the population of bacteria entirely resistant to a given antibiotics. For example, after the discovery of penicillin and its subsequent use to treat bacterial infections, bacteria were found to have begun producing an enzyme, penicillinase, which rendered the penicillin molecule inactive. In response to this newly-acquired resistance, newer penicillins were produced that could not
Antibiotic use in livestock United States that systematically collects detailed data on antibiotic use in humans and animals. It is not clear which antibiotics are prescribed for which purpose and at what time. Furthermore, the world has no surveillance infrastructure to monitor emerging antibiotic resistance threats. Because of these issues, it is difficult to quantify antibiotic resistance, to regulate antibiotic prescribing practices, and to detect and respond to rising threats. At this time, the most well-documented impact on humans is foodborne gastrointestinal illness. In most cases, these illnesses are mild and do not require antibiotics; though if the infectious bacteria is drug-resistant, they have